Progesterone Receptor-negative Breast Cancer Terminated Phase 2 Trials for Anastrozole (DB01217)

IndicationStatusPhase
DBCOND0028547 (Progesterone Receptor-negative Breast Cancer)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01234532Entinostat and Anastrozole in Treating Postmenopausal Women With TNBC That Can Be Removed by SurgeryTreatment